News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
477,050 Results
Type
Article (28617)
Company Profile (351)
Press Release (448082)
Section
Business (135493)
Career Advice (420)
Deals (24546)
Drug Delivery (74)
Drug Development (66364)
Employer Resources (65)
FDA (12172)
Job Trends (9917)
News (237707)
Policy (19213)
Tag
Academia (1803)
Alliances (36887)
Alzheimer's disease (1169)
Approvals (12167)
Artificial intelligence (172)
Bankruptcy (174)
Best Places to Work (8467)
Biotechnology (261)
Breast cancer (198)
Cancer (1542)
Cardiovascular disease (126)
Career advice (370)
CAR-T (117)
Cell therapy (347)
Clinical research (53654)
Collaboration (642)
Compensation (266)
COVID-19 (1977)
C-suite (153)
Data (1501)
Diabetes (187)
Diagnostics (4804)
Earnings (49740)
Events (80401)
Executive appointments (510)
FDA (12965)
Funding (550)
Gene therapy (245)
GLP-1 (578)
Government (2409)
Healthcare (12737)
Infectious disease (2064)
Inflammatory bowel disease (120)
IPO (12012)
Job creations (1926)
Job search strategy (343)
Layoffs (311)
Legal (3226)
Lung cancer (228)
Lymphoma (103)
Manufacturing (201)
Medical device (8925)
Medtech (8929)
Mergers & acquisitions (12923)
Metabolic disorders (482)
Neuroscience (1548)
NextGen: Class of 2025 (3672)
Non-profit (2661)
Northern California (1771)
Obesity (257)
Opinion (134)
Parkinson's disease (104)
Patents (122)
People (41908)
Phase I (17094)
Phase II (23624)
Phase III (17778)
Pipeline (647)
Postmarket research (1830)
Preclinical (7038)
Radiopharmaceuticals (240)
Rare diseases (304)
Real estate (3654)
Regulatory (14961)
Research institute (1836)
Series A (105)
Southern California (1529)
Startups (2664)
United States (15306)
Vaccines (473)
Weight loss (169)
Date
Today (72)
Last 7 days (499)
Last 30 days (2237)
Last 365 days (29662)
2025 (3805)
2024 (30157)
2023 (33607)
2022 (43710)
2021 (46640)
2020 (42593)
2019 (32186)
2018 (24094)
2017 (24507)
2016 (22908)
2015 (26833)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (436)
Arizona (109)
Asia (30452)
Australia (5297)
California (4044)
Canada (1390)
China (370)
Colorado (181)
Connecticut (180)
Europe (68696)
Florida (517)
Georgia (148)
Illinois (327)
Indiana (224)
Japan (116)
Maryland (595)
Massachusetts (3233)
Michigan (189)
Minnesota (240)
New Jersey (1177)
New York (1144)
North Carolina (701)
Northern California (1771)
Ohio (134)
Pennsylvania (875)
South America (630)
Southern California (1529)
Texas (515)
Washington State (388)
477,050 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s Disease
February 19, 2025
·
4 min read
Press Releases
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
January 29, 2025
·
5 min read
Press Releases
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
November 19, 2024
·
5 min read
Press Releases
Therapeutic Doses of Blood Thinners Decrease Mortality for Hospitalized COVID-19 Patients
December 24, 2024
·
3 min read
Press Releases
Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept
January 21, 2025
·
3 min read
Press Releases
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
February 10, 2025
·
6 min read
Mergers & acquisitions
Novartis Bets Up to $3.1B to Buy Back Blood Thinner in Anthos Acquisition
Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.
February 11, 2025
·
2 min read
·
Tristan Manalac
Business
The Leukemia & Lymphoma Society and Tasso Announce Partnership to Advance Blood Cancer Research
The Leukemia & Lymphoma Society®, a global leader in the fight against blood cancer, and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, announced a collaboration to accelerate blood cancer research.
May 30, 2024
·
3 min read
Press Releases
First Participant Dosed in Tisento Therapeutics’ Global Phase 2b PRIZM Study Evaluating Zagociguat for the Treatment of MELAS
January 27, 2025
·
4 min read
Press Releases
Thryv Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference in Miami, FL
February 3, 2025
·
1 min read
1 of 47,705
Next
